{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:52:11Z","timestamp":1785909131698,"version":"3.56.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vascular thrombosis remains a significant cause of early graft loss and morbidity in pediatric liver transplant (PLT) patients. However, no standardized protocol for thromboprophylaxis exists. This study aimed to evaluate appropriateness of continuous infusion of unfractionated heparin (UFH) prophylaxis in PLT patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study was conducted in a pediatric intensive care unit. Patients between the ages of 1 month to 14 years who received prophylactic continuous UFH infusion following PLT were included. The primary outcome was to examine the percentage of patients on intravenous continuous UFH infusion achieving the prophylactic aPTT target levels (40\u201360\u2005s) in PLT recipients whereas secondary outcomes were time to target, dose titrations, thrombotic events, bleeding complications and safety outcomes. Statistical analyses were performed using Stata software, version 18. For categorical variables, frequencies and percentages were used whereas continuous data was presented as median and interquartile range (IQR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 47 patients were included, with the majority constituting males (57.4%). Median heparin infusion duration was 55.93\u2005h [38.97\u201379.97]. All patients achieved prophylactic aPTT target levels, with 89.4% reaching the target within 24\u2005h. Median time to target achievement was 4.68\u2005h [4.00\u201312.53]. Most patients (63.8%) achieved target prophylactic anticoagulation without dose titration whereas 6.4% required \u22653 titrations. Only 2 patients (4.3%) reported thrombotic complications including one portal vein thrombosis and one hepatic vein thrombosis. Clinically significant bleeding was reported in 7 patients (14.9%), with only one patient requiring surgical re-intervention. Hypotension was observed in 40.4% of patients. Median PICU length of stay was 4 days [3\u20136].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Postoperative thromboprophylaxis with continuous UFH infusion at an initial dose of 10\u2005units\/kg\/hr was effective in achieving prophylactic anticoagulation in most PLT recipients. The protocol was associated with low thrombotic events and bleeding complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1916517","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:38:56Z","timestamp":1785908336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Heparin continuous infusion for thromboprophylaxis in pediatric liver transplant recipients"],"prefix":"10.3389","volume":"14","author":[{"given":"Khalid W.","family":"Taher","sequence":"first","affiliation":[{"name":"Pharmaceutical Care Division, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]},{"name":"Pharmacy Practice Department, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Alhawas","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Ansary","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laian","family":"Tarboush","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munirah","family":"Alshalawi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, College of Public Health and Health Informatics, King Saud bin Abdulaziz University for Health Sciences","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moath","family":"Alabdulsalam","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/children12040449","article-title":"Timing and indications for liver transplantation for children with chronic liver disease","volume":"12","author":"Suthantirakumar","year":"2025","journal-title":"Children (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1097\/TP.0000000000004644","article-title":"International liver transplantation society global census: first Look at pediatric liver transplantation activity around the world","volume":"107","author":"Rodriguez-Davalos","year":"2023","journal-title":"Transplantation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e929145","DOI":"10.12659\/AOT.929145","article-title":"Risk factors affecting outcomes in pediatric liver transplantation: a real-world single-center experience","volume":"26","author":"Hong","year":"2021","journal-title":"Ann Transplant"},{"key":"B4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5500\/wjt.v13.i3.96","article-title":"Long-term outcomes of pediatric liver transplantation in acute liver failure vs end-stage chronic liver disease: a retrospective observational study","volume":"13","author":"Alnagar","year":"2023","journal-title":"World J Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3748\/wjg.v22.i6.2005","article-title":"Coagulopathy and transfusion therapy in pediatric liver transplantation","volume":"22","author":"Nacoti","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e26955","DOI":"10.1002\/pbc.26955","article-title":"Bleeding and thrombotic complications of pediatric liver transplant","volume":"65","author":"Borst","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e14629","DOI":"10.1111\/ctr.14629","article-title":"What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and expert panel recommendations","volume":"36","author":"Kirchner","year":"2022","journal-title":"Clin Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/ajt.15748","article-title":"Evidence for a rebalanced hemostatic system in pediatric liver transplantation: a prospective cohort study","volume":"20","author":"Werner","year":"2020","journal-title":"Am J Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e13193","DOI":"10.1111\/petr.13193","article-title":"Perioperative anticoagulation practices for pediatric liver transplantation","volume":"22","author":"Voulgarelis","year":"2018","journal-title":"Pediatr Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"100630","DOI":"10.1016\/j.trre.2021.100630","article-title":"Portal vein obstruction after pediatric liver transplantation: a systematic review of current treatment strategies","volume":"35","author":"Alfares","year":"2021","journal-title":"Transplant Rev (Orlando)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1600-6143.2008.02541.x","article-title":"Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors","volume":"9","author":"Bekker","year":"2009","journal-title":"Am J Transplant"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511547409","volume-title":"Liver Disease in Children","author":"Suchy","year":"2007"},{"key":"B13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1053\/jlts.2003.50098","article-title":"Hepatic artery thrombosis after adult liver transplantation","volume":"9","author":"Stange","year":"2003","journal-title":"Liver Transpl"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1111\/j.1600-6143.2012.04204.x","article-title":"Reducing pediatric liver transplant complications: a potential roadmap for transplant quality improvement initiatives within North America","volume":"12","author":"Englesbe","year":"2012","journal-title":"Am J Transplant"},{"key":"B15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0140-6736(06)68033-1","article-title":"3-month And 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome","volume":"367","author":"Burroughs","year":"2006","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/1076029616680477","article-title":"Venous thrombotic events after liver transplantation","volume":"24","author":"Blasi","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"B17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.4254\/wjh.v10.i10.752","article-title":"Thrombosis prophylaxis in pediatric liver transplantation: a systematic review","volume":"10","author":"Nacoti","year":"2018","journal-title":"World J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2450\/2021.0388-20","article-title":"Post-operative heparin reduces early venous thrombotic complications after orthotopic paediatric liver transplantation","volume":"19","author":"Colombo","year":"2021","journal-title":"Blood Transfusion"},{"key":"B19","doi-asserted-by":"publisher","first-page":"S351","DOI":"10.1111\/jth.12968","article-title":"Pediatric transplantation: preventing thrombosis","volume":"13","author":"Robertson","year":"2015","journal-title":"J Thromb Haemostasis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1182\/asheducation-2018.1.399","article-title":"Management of thrombosis in children and neonates: practical use of anticoagulants in children","volume":"2018","author":"Monagle","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.transproceed.2011.01.011","article-title":"Management of early hepatic arterial thrombosis after pediatric living-donor liver transplantation","volume":"43","author":"Sevmis","year":"2011","journal-title":"Transplant Proc"},{"key":"B22","year":"2006"},{"key":"B23","year":"2024"},{"key":"B24","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.liver.2023.100185","article-title":"Vascular thrombosis after pediatric liver transplantation: is prevention achievable?","volume":"12","author":"Martinez","year":"2023","journal-title":"J Liver Transpl"},{"key":"B25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.hpb.2018.08.014","article-title":"Perioperative thrombotic complications associated with pediatric liver transplantation: a UNOS database evaluation","volume":"21","author":"Bezinover","year":"2019","journal-title":"HPB (Oxford)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.thromres.2010.05.015","article-title":"Evaluation of a post-operative thrombin inhibitor replacement protocol to reduce haemorrhagic and thrombotic complications after paediatric liver transplantation","volume":"126","author":"Hardikar","year":"2010","journal-title":"Thromb Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1399-0012.2008.00924.x","article-title":"The impact of meticulous management for hepatic artery thrombosis on long-term outcome after pediatric living donor liver transplantation","volume":"23","author":"Uchida","year":"2009","journal-title":"Clin Transplant"},{"key":"B28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1399-3046.2010.01426.x","article-title":"Anticoagulation following pediatric liver transplantation reduces early thrombotic events","volume":"15","author":"McLin","year":"2011","journal-title":"Pediatr Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e29898","DOI":"10.1002\/pbc.29898","article-title":"Early thrombotic and hemorrhagic complications associated with a risk-adjusted postoperative anticoagulation protocol after pediatric liver transplantation","volume":"69","author":"Lemoine","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/lt.26463","article-title":"A look into hemostatic characteristics during pediatric liver transplantation using the thromboelastometry (ROTEM\u00ae) test","volume":"28","author":"Cho","year":"2022","journal-title":"Liver Transpl"},{"key":"B31","doi-asserted-by":"publisher","first-page":"102709","DOI":"10.1016\/j.rpth.2025.102709","article-title":"Persisting thrombomodulin resistance at 3 months after liver transplantation in children with cirrhosis","volume":"9","author":"van Dievoet","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"B32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1055\/s-0031-1297162","article-title":"The coagulation system in children: developmental and pathophysiological considerations","volume":"37","author":"Ignjatovic","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"B33","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jpedsurg.2022.06.008","article-title":"Antithrombin supplementation for prevention of vascular thrombosis after pediatric liver transplantation","volume":"57","author":"Hukkinen","year":"2022","journal-title":"J Pediatr Surg"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1916517\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:38:57Z","timestamp":1785908337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1916517\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":33,"alternative-id":["10.3389\/fped.2026.1916517"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1916517","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"article-number":"1916517"}}